Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma
Jeffrey Bradley, Mary V. Graham, Kathryn Winter, James A. Purdy, Ritsuko Komaki, Wilson H. Roa, Janice K. Ryu, Walter Bosch, Bahman Emami
Dive into the research topics of 'Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma'. Together they form a unique fingerprint.